APA (7th ed.) Citation

Avallone, G., Margiotta, F. M., Bombelli, A., Gargiulo, L., Foti, C., Trave, I., . . . Veronese, F. (2026). Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area. Dermatology & Therapy, 1. https://doi.org/10.1007/s13555-026-01863-2

Chicago Style (17th ed.) Citation

Avallone, Gianluca, et al. "Treatment Outcomes of Lebrikizumab After Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis Involving the Head and Neck Area." Dermatology & Therapy 2026: 1. https://doi.org/10.1007/s13555-026-01863-2.

MLA (9th ed.) Citation

Avallone, Gianluca, et al. "Treatment Outcomes of Lebrikizumab After Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis Involving the Head and Neck Area." Dermatology & Therapy, 2026, p. 1, https://doi.org/10.1007/s13555-026-01863-2.